Rivernorth Capital Management’s Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant WRAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-90,568
Closed -$922K 748
2021
Q3
$922K Buy
+90,568
New +$908K 0.05% 280

Other funds holding WRAC.U

Rivernorth Capital Management's WRAC.U Position: Q4 2021 in Review

Rivernorth Capital Management sold out of Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant (WRAC.U) in Q4 2021, closing a stake of 90,568 shares — an estimated $922K sold.

Rivernorth Capital Management first reported a position in WRAC.U in Q3 2021 and held it in 1 quarter. The position peaked at $922K in Q3 2021. 24 funds tracked by Wall St. Rank hold WRAC.U as of Q4 2021.

  • Rivernorth Capital Management reported no remaining Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Rivernorth Capital Management sold 90,568 Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $922K.
  • Rivernorth Capital Management first reported a position in Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant in Q3 2021 and held it in 1 quarter.
  • Rivernorth Capital Management's Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant position peaked at $922K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Rivernorth Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.